Bayzed Health Group Inc (HKG:2609)
Hong Kong
· Delayed Price · Currency is HKD
3.320
+0.070 (2.15%)
Mar 10, 2026, 2:13 PM HKT
Bayzed Health Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 1,193 | 1,189 | 1,072 | 802.65 | 461.59 |
| Revenue Growth (YoY) | 4.65% | 10.88% | 33.58% | 73.89% | - |
| Cost of Revenue | 976.33 | 980.65 | 894.01 | 723.1 | 420.2 |
| Gross Profit | 216.3 | 208.2 | 178.16 | 79.56 | 41.39 |
| Selling, General & Admin | 196.9 | 177.53 | 160.64 | 120.61 | 82.54 |
| Other Operating Expenses | -2.97 | -2.13 | -4.17 | -3.75 | -1.6 |
| Operating Expenses | 195.48 | 176.05 | 156.74 | 118.92 | 81.4 |
| Operating Income | 20.82 | 32.15 | 21.42 | -39.36 | -40.01 |
| Interest Expense | -20.42 | -21.5 | -26.66 | -23.62 | -20.95 |
| Interest & Investment Income | 2.62 | 2.84 | 1.19 | 1.32 | 5.9 |
| Other Non Operating Income (Expenses) | -0.15 | -0.18 | -0.39 | -0.82 | -0.11 |
| EBT Excluding Unusual Items | 2.87 | 13.31 | -4.43 | -62.48 | -55.17 |
| Gain (Loss) on Sale of Assets | -0.01 | 0 | -0.18 | -0.04 | 0.33 |
| Pretax Income | 2.86 | 13.31 | -4.61 | -62.52 | -54.84 |
| Income Tax Expense | 19.34 | 16.87 | 19.8 | 12.99 | 7.12 |
| Earnings From Continuing Operations | -16.48 | -3.56 | -24.41 | -75.52 | -61.96 |
| Minority Interest in Earnings | -13.05 | -9.9 | -1.98 | 17.5 | 15.86 |
| Net Income | -29.53 | -13.46 | -26.39 | -58.02 | -46.09 |
| Net Income to Common | -29.53 | -13.46 | -26.39 | -58.02 | -46.09 |
| Shares Outstanding (Basic) | 1,318 | 1,185 | 1,185 | - | - |
| Shares Outstanding (Diluted) | 1,318 | 1,185 | 1,185 | - | - |
| EPS (Basic) | -0.02 | -0.01 | -0.02 | - | - |
| EPS (Diluted) | -0.02 | -0.01 | -0.02 | - | - |
| Free Cash Flow | 139.69 | 124.67 | 83 | 84.96 | -42.65 |
| Free Cash Flow Per Share | 0.11 | 0.10 | 0.07 | - | - |
| Gross Margin | 18.14% | 17.51% | 16.62% | 9.91% | 8.97% |
| Operating Margin | 1.75% | 2.70% | 2.00% | -4.90% | -8.67% |
| Profit Margin | -2.48% | -1.13% | -2.46% | -7.23% | -9.98% |
| Free Cash Flow Margin | 11.71% | 10.49% | 7.74% | 10.59% | -9.24% |
| EBITDA | 81.05 | 90.84 | 80.99 | 10.62 | -8.77 |
| EBITDA Margin | 6.80% | 7.64% | 7.55% | 1.32% | -1.90% |
| D&A For EBITDA | 60.23 | 58.69 | 59.57 | 49.98 | 31.24 |
| EBIT | 20.82 | 32.15 | 21.42 | -39.36 | -40.01 |
| EBIT Margin | 1.75% | 2.70% | 2.00% | -4.90% | -8.67% |
| Effective Tax Rate | 675.79% | 126.72% | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.